abstract |
The present invention relates to substituted pyrimidine derivatives represented by formula (I) or (Ia) and their tautomers, hydrates, solvates, esters or pharmaceutically acceptable salts for inhibiting Aurora kinase , and pharmaceutical compositions containing these compounds as active ingredients, and the use of the compounds and their pharmaceutical compositions to prepare medicines for preventing, treating, treating or alleviating proliferative diseases in patients. |